| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/15/2004 | WO2004031736A1 Burrless embedding pharmaceutical preparation plate for pathological tissue sample, embedding phamaceutical preparation frame, cassette, and embedding pharmaceutical preparation method |
| 04/15/2004 | WO2004031732A2 Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same |
| 04/15/2004 | WO2004031730A2 High sensitivity quantitation of peptides by mass spectrometry |
| 04/15/2004 | WO2004031727A2 Methods for diagnosing bone turnover disease |
| 04/15/2004 | WO2004031725A2 Ratios of collagen peptides, their uses and products |
| 04/15/2004 | WO2004031724A2 Apparatus and method for expression and capture of biomolecules and complexes on adsorbent surfaces |
| 04/15/2004 | WO2004031723A2 Method and apparatus for hemostasis and blood management |
| 04/15/2004 | WO2004031722A2 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 04/15/2004 | WO2004031721A2 Detection of biological threat agents |
| 04/15/2004 | WO2004031412A2 Method for diagnosing pancreatic cancer |
| 04/15/2004 | WO2004031411A2 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031404A1 Protein labelling with o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004031397A2 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 04/15/2004 | WO2004031386A1 Method of examining atopic dermatitis |
| 04/15/2004 | WO2004031384A1 Mouse-origin proteins forming domain or use thereof |
| 04/15/2004 | WO2004031367A2 Uses of human zven proteins and polynucleotides |
| 04/15/2004 | WO2004031365A2 Sulfatases and methods of use thereof |
| 04/15/2004 | WO2004031358A2 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 04/15/2004 | WO2004031354A2 Human sarcoma-associated antigens |
| 04/15/2004 | WO2004031344A2 Characterizing nucleic acid and amino acid sequences in silico |
| 04/15/2004 | WO2004031332A2 System for identifying the lubricating oil in a machine |
| 04/15/2004 | WO2004031311A2 Combinatorial screening/testing apparatus and method |
| 04/15/2004 | WO2004031241A1 Monoclonal antibody against subtilisin-like proprotein convertase pace4 and utilization thereof |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031144A2 Use of caspase inhibitors as therapeutic agent against radiation-induced injury |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030826A2 Buffy coat separator float system and method |
| 04/15/2004 | WO2004030822A1 Multiple capillary sensor analysis system |
| 04/15/2004 | WO2004030821A1 Device for determining and displaying at least one physical, chemical or biological property of a test liquid |
| 04/15/2004 | WO2004030721A2 Fluid collecting device, methods of production and uses thereof |
| 04/15/2004 | WO2004030719A2 Hemostatic puncture closure with depth indicator |
| 04/15/2004 | WO2004030699A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/15/2004 | WO2004030695A1 Treatment of vascular diseases |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030622A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 04/15/2004 | WO2004030533A1 Apparatus for monitoring a patient |
| 04/15/2004 | WO2004030522A2 Diagnosis and monitoring of diseases |
| 04/15/2004 | WO2004030521A2 Use of biomarkers for detecting acute renal transplant rejection |
| 04/15/2004 | WO2004030511A2 Prostate cancer biomarkers |
| 04/15/2004 | WO2004018623A3 Substrates for isolating, reacting and microscopically analyzing materials |
| 04/15/2004 | WO2004014948A3 Gpi anchored glycoprotein aca as a novel tumor marker |
| 04/15/2004 | WO2004013634A3 Dna damage repair polypeptide and uses thereof |
| 04/15/2004 | WO2004013619A3 Method and device for in-line measurement of characteristics of the surface coating of a metallurgy product |
| 04/15/2004 | WO2004012757A3 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 04/15/2004 | WO2004009847A3 Functional screening method involving protein translocation/redistribution |
| 04/15/2004 | WO2004005550A3 Method of screening for antidiabetic agents |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003107009A3 Methods for improving a binding characteristic of a molecule |
| 04/15/2004 | WO2003104803A3 Method for mapping and eliminating t-cell epitopes |
| 04/15/2004 | WO2003102579A3 Method of screening groups of radioactive molecules and applications thereof |
| 04/15/2004 | WO2003102218A3 Hybrid microcantilever sensors |
| 04/15/2004 | WO2003095619A3 Protein complex purification |
| 04/15/2004 | WO2003093505A3 Method for determining the presence of an unconventional transmissible agent responsible for transmissible subacute spongiform encephalopathy |
| 04/15/2004 | WO2003093323A9 Automated sequential injection analysis systems for the determination of trace endotoxin levels |
| 04/15/2004 | WO2003091304A3 Solid supports functionalised by phosphorus dendrimers, method for preparing same and uses thereof |
| 04/15/2004 | WO2003089457B1 Peptide inhibitors of protein kinase c ϝ for pain management |
| 04/15/2004 | WO2003088922A3 E7 regulation of p21cip1 through akt |
| 04/15/2004 | WO2003087289A8 Methods for the selection of compounds useful for the treatment of huntington’s disease |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003083490A3 Method for predicting antiphospholid syndrome |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | WO2003078582B1 Integrated system for high throughput capture of genetic diversity |
| 04/15/2004 | WO2003075835A3 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003062451A3 Fluorogenic dyes |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003054543A3 Probe for mass spectrometry |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003048719A3 Device for detecting oil penetration into the measuring chamber of a gas sensor connected to a transformer chamber by means of a membrane, and heating device for transformer oil |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003040678A3 Fluorescence quenching used to detect ligate/ligand association events in electrical fields |
| 04/15/2004 | WO2003040386A3 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids |
| 04/15/2004 | WO2003019142A3 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 04/15/2004 | WO2003019140A3 Method for molecular subshape similarity matching |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2003018776A9 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 04/15/2004 | WO2003012440A8 Method and system for predicting initial analyte values in stored samples |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002756A9 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002101391A3 Method of use |
| 04/15/2004 | WO2002100265A9 Control solution packets and methods for calibrating fluid sampling devices |
| 04/15/2004 | WO2002099410A9 Sensor device and method for indicating oxygen consumption |
| 04/15/2004 | WO2002090993A3 Functional protein expression for rapid cell-free phenotyping |
| 04/15/2004 | WO2002081740A3 Supported double-layer structure for displaying a nucleic acid associated with a protein |
| 04/15/2004 | WO2002068958A8 Molecularly imprinted scintillation polymers |
| 04/15/2004 | WO2002064763A8 Novel human poly(a)polymerase gamma (pap gamma) |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002048403B1 Multiplexed protein expression and activity assay |
| 04/15/2004 | WO2002034953A3 Detection and quantification of human herpes viruses |
| 04/15/2004 | WO2002033403A8 Filtration container |